Published research
View all research (19)
2026
Quercetin targets IGF1 signaling in gastric cancer: a synergy of network pharmacology, molecular simulations, and in vitro functional assays
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
Neuroprotective Effects of Conessine in Beta-Amyloid- Induced SH-SY5Y Cells in vitro
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH
Morin Suppresses Invasion and Migration in TGF-?–stimulated Colorectal Cancer Cells Via Modulation of the Wnt/?-catenin Signaling Pathway: An In vitro Study
JOURNAL OF PHARMACEUTICAL INNOVATION
Rifabutin Loaded Biogenic Silver Nanoparticles: Development, Characterization, and Evaluation of Antidiabetic Activity in Streptozotocin Induced Diabetic Rats
CHEMISTRY & BIODIVERSITY
Vitamin D Promotes Neuronal Survival via Nrf2 Upregulation in D-Galactose–Induced Mice: An In-Vivo and In-Silico Study
JOURNAL OF NEUROIMMUNE PHARMACOLOGY
Impact of Semaglutide as Weight Management Medication on Clinical Parameters and Health-Related Quality of Life: A Single-Center Study from Saudi Arabia
MDPI
Investigation of Anti-Cancer Potency of Sarsasapogenin: In vitro and in silico Insights against MDR Cell Line-KB-Chr-8-5
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH
2025
Semaglutide in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights
MDPI
Evaluation of Pre-Treatment Assessment of Semaglutide Users: Balancing the Benefits ofWeight Loss vs. Potential Health Consequences
MDPI
Role of Thymus ciliatus (Thyme) to Ameliorate the Acute Neurotoxicity Induced by Bisphenol A: In Vivo Supported with Virtual Study
MDPI
2024
Effect of Drying on the Quantity and Composition of Artemisia monosperma Essential Oil and Exploring the Bronchodilator Effect Using Guinea Pig Tracheal Muscles
ACG Publications
Risperidone-induce rhabdomyolysis via inhibition of mitochondrial respiratory complex I and III,
Dubai International Pharmaceutical & Technologies Conference & Exhibition
2021
Mitochondrial liability of drugs suspected to induce rhabdomyolysis in the U.S. Food and Drug Administration Adverse Event Reporting System in L6 rat skeletal muscle
European Federation for Pharmaceutical Sciences (EUFEPS), Germany.
Examining the mitochondrial liability of the most frequently reported drugs suspected to induce rhabdomyolysis to the U.S. Food and Drug Administration Adverse Event Reporting System in L6 rat skeletal muscle cells
EUFEPS European Federation for Pharmaceutical Sciences
2022
Risperidone-induce rhabdomyolysis via inhibition of mitochondrial respiratory complex I and III,
Cell Symposia: Multifaceted Mitochondria Seville, Spain.
Assessing direct mitochondrial toxicity as a mechanism of drug-induced rhabdomyolysis
British Toxicology Society (BTS)
Clinical consequences of drug-induced mitochondrial dysfunction
Elsevier
2020
An assessment of drug-induced rhabdomyolysis cases within the U.S. Food and Drug Administration Adverse Event Reporting System
British Pharmacology Society (BPS)
2023
Developing In Vitro Models to Define the Role of Direct Mitochondrial Toxicity in Frequently Reported Drug-Induced Rhabdomyolysis
Biomedicines